Validation of the JADE wRAP™, a Novel Blood Pressure Measurement Device, Using the Same Arm Sequential Method

Sponsor
Jade Healthcare Group Inc. (Industry)
Overall Status
Recruiting
CT.gov ID
NCT03452280
Collaborator
Allphase Clinical Research Inc. (Other)
140
1
48.4
2.9

Study Details

Study Description

Brief Summary

The JADE wRAP™, a wrist worn cuff to measure blood pressure and its supporting software platform is currently at the final alpha prototype stage of development and is not intended for sale.

There are minimal risks with using the JADE wRAP™ device; however, the likelihood of these risks has been reduced through design limitations on electrical power delivered to the device and of the pressure delivered to the cuff portion. Patients should experience little to no discomfort from the inflation of the JADE wRAP™ cuff.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    The purpose of this study is to validate the JADE wRAP™ in adult patients (≥18 years of age) according to American National Standard, ANSI/AAMI/ISO 81060-2:2013, Non-invasive sphygmomanometers - Part 2: Clinical investigation of automated measurement type.

    The study is intended to be a simple validation of blood pressure parameters only (Systolic and Diastolic). This study is not intended to yield any other special information.

    OBJECTIVES

    1. To validate the JADE wRAP™ for systolic and diastolic blood pressures compared to the reference standard mercury sphygmomanometer.

    The data collected from this study is for internal purposes only and should assist in further developing the device and supporting platform to a beta stage.

    Study Design

    Study Type:
    Observational
    Anticipated Enrollment :
    140 participants
    Observational Model:
    Case-Only
    Time Perspective:
    Other
    Official Title:
    Validation of the JADE wRAP™, a Novel Blood Pressure Measurement Device, Using the Same Arm Sequential Method
    Actual Study Start Date :
    Dec 18, 2017
    Anticipated Primary Completion Date :
    Dec 31, 2021
    Anticipated Study Completion Date :
    Dec 31, 2021

    Outcome Measures

    Primary Outcome Measures

    1. Validation Criteria 1 [April 30, 2018]

      For systolic and diastolic blood pressures, the mean value of the differences of the determinations, of the n individual paired determinations of the JADE wRAPTM and of the observers' determinations with the reference sphygmomanometer for all subjects shall be within or equal to ± 5.0 mmHg (± 0.67 kPa), with a standard deviation, sn, no greater than 8.0 mmHg (1.07 kPa)

    Secondary Outcome Measures

    1. Validation Criteria 2 [April 30, 2018]

      For the systolic and diastolic blood pressures for each of the m subjects, the standard deviation, sm, of the averaged paired determinations per subject of the JADE wRAPTM and of the observers' determinations with the reference sphygmomanometer shall meet the criteria listed.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    1. Must be at least 18 years of age

    2. Male or Female

    3. Must provide written informed consent prior to the performance of any study-related procedures.

    Exclusion Criteria:
    1. Subjects who in the opinion of the study staff are too agitated, distressed or who are otherwise unable to cooperate with study procedures

    2. Subjects with bigeminy, trigeminy, isolated ventricular premature beat (VPD) or atrial fibrillation or any other condition, in the opinion of the study staff that can result in a significantly irregular heath rhythm.

    3. Subjects with signs or recent history of inflammation or infection of the wrists or at the reference clinical test site.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Alio Health Services Inc. Ottawa Ontario Canada K2K 2E3

    Sponsors and Collaborators

    • Jade Healthcare Group Inc.
    • Allphase Clinical Research Inc.

    Investigators

    • Principal Investigator: Jeff Smith, Alio Health Services Inc.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Jade Healthcare Group Inc.
    ClinicalTrials.gov Identifier:
    NCT03452280
    Other Study ID Numbers:
    • BP1
    First Posted:
    Mar 2, 2018
    Last Update Posted:
    Feb 11, 2021
    Last Verified:
    Feb 1, 2021
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No

    Study Results

    No Results Posted as of Feb 11, 2021